Can Troponin Be Used as a Prognostic Marker in Cancer?
Yes, troponin can serve as a prognostic marker in cancer. Several studies have shown that elevated troponin levels in cancer patients, particularly those undergoing cardiotoxic treatments, are linked to adverse outcomes such as heart failure and reduced overall survival. Monitoring troponin levels can help in risk stratification and guide therapeutic decisions.